Author Archives for Adeline Chauvigné

OSE Immunotherapeutics Receives €5.2 M in Public Funding for the Clinical Development of CoVepiT, its Second Generation COVID-19 Vaccine

• CoVepiT demonstrated generation of sentinel memory T cells with long-term protective effect against COVID-19 in preclinical and human ex... View Article

Rédigé par Adeline Chauvigné, le 2021-01-15

OSE Immunotherapeutics Receives €5.2 M in Public Funding for the Clinical Development of CoVepiT, its Second Generation COVID-19 Vaccine

• CoVepiT demonstrated generation of sentinel memory T cells with long-term protective effect against COVID-19 in preclinical and human ex... View Article

Valneva Initiates Phase 1/2 Clinical Study of Inactivated, Adjuvanted COVID-19 Vaccine Candidate

Valneva SE, a specialty vaccine company focused on prevention against diseases with major unmet needs, today announced the initiation of... View Article

Rédigé par Adeline Chauvigné, le 2020-12-16

Valneva Initiates Phase 1/2 Clinical Study of Inactivated, Adjuvanted COVID-19 Vaccine Candidate

Valneva SE, a specialty vaccine company focused on prevention against diseases with major unmet needs, today announced the initiation of... View Article

New member | Substra Foundation

Substra Foundation is an independent nonprofit organization dedicated to fostering the development of trustworthy data science ecosystems. It promotes, protects... View Article

Rédigé par Adeline Chauvigné, le 2020-12-14

New member | Substra Foundation

Substra Foundation is an independent nonprofit organization dedicated to fostering the development of trustworthy data science ecosystems. It promotes, protects... View Article

BHealthCare raises € 1.5 M to finalise development of its robotic blood sampling platform, HEIVA™

BHealthCare, a MedTech specialising in the development of next-generation robotic solutions to provide more reliable peripheral vascular access, has announced... View Article

Rédigé par Adeline Chauvigné, le 2020-12-10

BHealthCare raises € 1.5 M to finalise development of its robotic blood sampling platform, HEIVA™

BHealthCare, a MedTech specialising in the development of next-generation robotic solutions to provide more reliable peripheral vascular access, has announced... View Article

The “France Relance” stimulus package: the Healthcare Clusters network proposes three options to guarantee French healthcare sovereignty

Improve access to equity by launching novel specialised investment funds Support research and innovation by issuing calls for projects with... View Article

Rédigé par Adeline Chauvigné, le 2020-12-10

The “France Relance” stimulus package: the Healthcare Clusters network proposes three options to guarantee French healthcare sovereignty

Improve access to equity by launching novel specialised investment funds Support research and innovation by issuing calls for projects with... View Article

A Nanofitins production unit: a project run by Affilogic, winner of the industrial relocation plan

Affilogic, a company specialising in the discovery and development of Nanofitins® for biotherapeutic applications, is one of the 31 projects... View Article

Rédigé par Adeline Chauvigné, le 2020-12-10

A Nanofitins production unit: a project run by Affilogic, winner of the industrial relocation plan

Affilogic, a company specialising in the discovery and development of Nanofitins® for biotherapeutic applications, is one of the 31 projects... View Article

Atlanpole Biotherapies | Customized services

Broadly speaking, cluster members are offered customized services that open up a path to European funding aimed at boosting innovation... View Article

Rédigé par Adeline Chauvigné, le 2020-12-10

Atlanpole Biotherapies | Customized services

Broadly speaking, cluster members are offered customized services that open up a path to European funding aimed at boosting innovation... View Article

Valneva prepares for Potential US IPO

Valneva SE (“Valneva” or “the Company”), a specialty vaccine company, today announced that it will convene an Extraordinary General Meeting (EGM)... View Article

Rédigé par Adeline Chauvigné, le 2020-12-02

Valneva prepares for Potential US IPO

Valneva SE (“Valneva” or “the Company”), a specialty vaccine company, today announced that it will convene an Extraordinary General Meeting (EGM)... View Article

Hemarina and Brest University Hospital (CHRU de Brest): OxyOp2 clinical trial proceeds successfully in all french transplant centers

Brest University Hospital and Hemarina, a biotech company based in Brittany, announced today they have successfully  topped the 100 people involved in... View Article

Rédigé par Adeline Chauvigné, le 2020-11-26

Hemarina and Brest University Hospital (CHRU de Brest): OxyOp2 clinical trial proceeds successfully in all french transplant centers

Brest University Hospital and Hemarina, a biotech company based in Brittany, announced today they have successfully  topped the 100 people involved in... View Article

New member | Imagin VR

Imagin VR is a company specialised in designing immersive, interactive and collaborative Virtual Reality devices, as well as developing VR... View Article

Rédigé par Adeline Chauvigné, le 2020-11-25

New member | Imagin VR

Imagin VR is a company specialised in designing immersive, interactive and collaborative Virtual Reality devices, as well as developing VR... View Article